Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: AIDS Behav. 2012 Aug;16(6):1670–1680. doi: 10.1007/s10461-011-0111-z

Correlates and contexts of U.S. injection drug initiation among undocumented Mexican migrant men who were deported from the United States

Angela M Robertson 1, Remedios Lozada 2, Robin A Pollini 3, Gudelia Rangel 4, Victoria D Ojeda 1
PMCID: PMC3624897  NIHMSID: NIHMS352230  PMID: 22246511

Abstract

Preventing the onset of injection drug use is important in controlling the spread of HIV and other blood borne infections. Undocumented migrants in the United States face social, economic, and legal stressors that may contribute to substance abuse. Little is known about undocumented migrants’ drug abuse trajectories including injection initiation. To examine the correlates and contexts of U.S. injection initiation among undocumented migrants, we administered quantitative surveys (n=309) and qualitative interviews (n=23) on migration and drug abuse experiences to deported male injection drug users (IDUs) in Tijuana, Mexico. U.S. injection initiation was independently associated with ever using drugs in Mexico pre-migration, younger age at first U.S. migration, and U.S. incarceration. Participants’ qualitative interviews contextualized quantitative findings and demonstrated the significance of social contexts surrounding U.S. injection initiation experiences. HIV prevention programs may prevent/delay U.S. injection initiation by addressing socio-economic and migration-related stressors experienced by undocumented migrants.

Keywords: HIV/AIDS, undocumented migrants, injection drug use, injection initiation, Mexico

INTRODUCTION

In the United States, Hispanics are overrepresented among persons living with HIV and hepatitis C virus (HCV) [1-3]. Although illicit drug use is less prevalent among Mexican migrants than U.S.-born Mexicans and non-Latino whites [4], undocumented Mexican migrants who use drugs experience heightened HIV risk [5, 6]. Undocumented migrants also experience severe social and economic marginalization including discrimination, unemployment, and residence in neighborhoods where drug abuse is highly prevalent [7, 8]. In combination with fear of deportation, a type of forced or involuntary return migration, these factors likely contribute to high levels of stress [9], which may contribute to substance abuse as a coping mechanism [10].

Deportees represent an important and underserved population at risk of HIV transmission and other health problems [11, 12]. Deportation, which is common in the U.S.-Mexico context [13], is increasingly triggered by drug-related criminal offenses [14, 15]. Most deportees (89%) are men [16], and many report history of substance abuse [14, 15] and engagement in risky behaviors for HIV transmission throughout their migration trajectories [17]. In 2010, ~40% of U.S. deportees to Mexico were released in Baja California, with Tijuana receiving the largest share at >126,000 persons [16]. With an estimated 1.6 million residents, Tijuana is the largest and fastest-growing city on Mexico’s Northern border with the United States [18]. Drug abuse is prevalent due to availability of drugs en route to the United States [19-21]. Research by our binational team found that deportees in Tijuana experience many harms relating to drug abuse [11], including HIV transmission: among male injection drug users (IDUs), those reporting U.S. deportation had four times higher odds of HIV infection than men who were not deported [12]. A qualitative pilot study designed to investigate this association found that deported IDUs report complex, lengthy migration and drug abuse trajectories with many formative exposures to and direct experiences with illicit drug use occurring pre-deportation. In particular, some men described beginning to inject drugs in the United States [17].

The transition from non-injection to injection drug use dramatically increases the risk of transmitting HIV and other blood borne infections including hepatitis B virus (HBV) and HCV [22-26]. The period immediately following injection initiation is marked by high HBV and HCV incidence [27, 28], with rates that may exceed 35/100 person-years [22, 24, 29-32]. New injection drug users (IDUs) may rely on assistance from others to inject [33], which is associated with increased risk of HIV infection [28]. New IDUs are also less likely to self-identify as injectors, reducing their visibility to prevention and treatment programs [23, 27]. With increasing duration of injection, IDUs experience higher risk of drug dependence, overdose, and other infections (e.g., abscesses) than non-injection drug users [34, 35]. Preventing injection initiation and reaching IDUs immediately following their transition to injection have thus been identified as important public health goals [36].

Preventing injection initiation requires a thorough understanding of individual, social and contextual factors associated with the transition to injection [36]. Injection initiation has been associated with socio-demographic factors including older age, male sex, and homelessness; heavy or frequent use of heroin, cocaine, or crack; younger age at first drug use; having peers or sex partners who inject drugs; history of physical or sexual abuse; exchanging sex for drugs; and residing in neighborhoods with large proportions of minority residents and low adult education levels [37-44]. Since injection is a highly efficient drug administration route, drug users may transition to injection due to increasing drug dependence, higher drug prices or reductions in purity, or changing forms of drugs that are locally available. For example, black tar heroin, which is the most common formulation found in the Western United States and Mexico, is difficult to smoke or snort but can be dissolved in water for injection [36, 45, 46]. Social norms and influence from peers, sex partners, family and community members may also promote injection initiation [47-50].

Although few studies have examined the transition to injection prospectively [31, 41, 43, 51], recent research among Mexican American heroin users in San Antonio found higher injection initiation rates than reported elsewhere, which the authors hypothesize may result from persistent poverty, social isolation, and a local subculture that normalizes heroin use and drug injection [48, 52, 53]. No studies to our knowledge have comprehensively examined critical transitions, including injection initiation, in undocumented Mexican migrants’ drug abuse trajectories. Research with undocumented migrants presents challenges in identifying, approaching, and recruiting participants [54]. Thus, we sought to examine undocumented migrants’ U.S. injection initiation by analyzing data from a unique sample of deported male IDUs residing in Tijuana, Mexico.

We built upon Rhodes’ risk environment framework, which emphasizes how social and environmental factors shape individuals’ drug abuse experiences and related harms at multiple levels [55]. We modified this framework to consider how undocumented migrants move through diverse social and geographic risk environments. Within migrants’ changing physical locations and life stages, acculturative stress and social and cultural experiences may influence transitions in drug abuse, particularly for adolescent migrants [56]. We therefore conceptualized three contexts in which undocumented migrants’ injection initiation may be influenced: (1) the pre-migration context in Mexico, (2) initial U.S. migration experiences, and (3) life as an undocumented migrant in the United States. Based on the injection initiation literature and our formative research among male IDUs deported to Mexico [17], we hypothesized that men with exposure to drugs in Mexico pre-migration would be more likely to initiate injecting in the United States than those without pre-migration exposure to drugs.

METHODS

Study Design

Our study drew from Proyecto El Cuete, a prospective study of HIV and syphilis among 1,056 IDUs in Tijuana, Mexico [57]. In 2006-2007, outreach workers recruited IDUs using respondent-driven sampling (RDS) [58]. Briefly, a diverse group of “seeds” were given uniquely coded coupons to recruit their peers, who were in turn trained to recruit their peers [59]; recruitment continued until the desired sample was achieved [58]. Eligibility criteria included being at least 18 years of age, injecting drugs in the past month, speaking Spanish/English, planning to reside in Tijuana for the next 18 months, and providing informed consent.

For this mixed-methods study of U.S. injection initiation, we drew from quantitative and qualitative sub-studies nested within Proyecto El Cuete. We collected our exploratory qualitative data in 2008 and used emergent themes regarding migration and deportation [17] to develop domains and measures for the quantitative questionnaire administered in 2010 [60]. For the two-phase, explanatory mixed methods study design presented here, we first analyzed the quantitative survey data and subsequently drew from qualitative interview data to help explain our quantitative findings (i.e., we used qualitative data to help explain and contextualize the independent correlates of U.S. injection initiation obtained from multivariable logistic regression analyses) [61]. The Human Research Protections Program of the University of California, San Diego and the Ethics Board of the Tijuana General Hospital approved all research protocols.

Quantitative Data Collection

For both sub-studies, we generated a list of all Proyecto El Cuete participants reporting U.S. deportation (n = 377). Eligibility included being male, not lost to follow-up from the parent study, and confirming U.S. deportation. For our quantitative study, outreach workers attempted to recruit all deported male participants; 328 men were not lost to follow-up and completed questionnaires (87% response rate).

From January–April 2010, quantitative interviews were conducted in English or Spanish, depending on participants’ preferences, in private rooms in the parent study’s storefront offices in Tijuana’s zona norte, an area characterized by high prevalence of drug abuse and proximity to the U.S. border. To ensure quality and consistency, trained interviewers used laptop computers to administer ~1 hour long computer assisted programmed interviews (CAPI) with automatic skip patterns and built in reliability checks. Questionnaire development was informed by our formative qualitative work [17], theoretical framework, and extensive pilot testing. Measures covered the key domains in our theoretical framework, including socio-demographics (e.g., age), pre-migration experiences (e.g., birthplace, family income, educational attainment, employment, and family and personal drug use before migration), initial migration experiences (e.g., ages at independence from family and first U.S. migration, reason for emigration, circumstances of travel), and U.S. experiences (e.g., U.S. social networks, places lived, total duration of U.S. residence, drug abuse behaviors, and incarceration experiences). U.S. injection initiation, the binary dependent variable for this study, was measured by the question, “Was the United States the first place where you ever injected drugs?” Participants were reimbursed U.S. $20 for their time.

Quantitative Data Analysis

We excluded 19 men who injected drugs in Mexico pre-migration from our quantitative analysis, resulting in a final sample of 309 men who reported injection initiation following their first migration to the U.S. We examined distributional differences between groups of men who did vs. did not report U.S. injection initiation using Wilcoxon rank sum tests for continuous variables and Pearson’s chi-square tests for binary and categorical variables. Univariate logistic regression identified correlates of U.S. injection initiation. For final multivariable logistic regression models, we considered all domains of our theoretical framework and variables attaining significance levels <10% in univariate models. We compared models using likelihood ratio tests and assessed collinearity and all two-way interactions. To correct for differential recruitment bias by U.S. injection initiation status, we calculated inverse probability weights based on individualized recruitment weights using the RDS Analysis Tool [62]. To account for correlation between recruiter and recruitee, we used the variable containing these weights as a cluster variable in a generalized estimating equation (GEE) algorithm. We assumed an exchangeable correlation structure within each cluster (i.e., that the correlation between any two subjects recruited by the same recruiter was the same). Correspondingly, all multivariate results presented are labeled “RDS-adjusted.”

Qualitative Data Collection

Sampling for our qualitative sub-study was based on the list of Proyecto El Cuete male deportees, participant availability, and diversity in the total number of U.S. deportations and time elapsed since most recent deportation (i.e., to achieve maximum variation with respect to deportation characteristics) [17]. From October–November 2008, a trained male interviewer conducted semi-structured, in-depth interviews lasting ~90 minutes in the private rooms described above. Open-ended questions focused on migration, deportation, drug use and sexual risk behaviors for HIV transmission (e.g., “Tell me about the first time you ever injected drugs.”) To ensure quality and consistency in data collection, the semi-structured interview guide also contained specific probes relating to places, people, and risk behaviors surrounding key events. Since men reported lengthy, complicated migration histories, participants were asked to focus on events surrounding their most recent deportation [17]. We terminated participant recruitment after interviewing 24 men, when saturation of themes was obtained [63]. Participants were reimbursed U.S. $20 for their time.

Qualitative Data Analysis

Qualitative interviews were digitally recorded and transcribed verbatim. To preserve the content of participants’ interviews, Spanish and bilingual transcripts were not translated into English. Our preliminary analysis involved creating an initial coding scheme for key concepts and categories, as previously described [17]. Briefly, this coding scheme was developed using a consensus approach in which a team of bilingual research assistants and the principal investigator independently applied codes and then compared coded text to discuss and resolve discrepancies [17]. To apply finalized codes, all transcripts were uploaded into ATLAS.ti, a qualitative data management software [64].

The present analysis of U.S. injection initiation is restricted to 23 men who also completed the 2010 quantitative surveys. We used the coding scheme [17] to obtain text segments coded for U.S. drug use and injection events. Next, we further analyzed these coded text segments to see where and how the qualitative data could help explain and/or contextualize our quantitative results [60, 65]. We selected relevant text segments (i.e., quotes) to explain each quantitative finding and illustrate additional social context surrounding their men’s U.S. injection experiences. The bilingual principal investigator (VO) translated all Spanish language quotes presented here.

RESULTS

Quantitative Findings: Factors Associated with U.S. Injection Initiation

Of the 309 deported male IDUs who reported initiating drug injection following their first migration to the U.S., 114 (37%) reported U.S. injection initiation. Table I presents results from univariate analyses comparing characteristics within each of the three theoretically derived contexts for men who did and did not initiate injection in the United States. First, in the pre-migration Mexico context, a minority of our sample was born in Tijuana and most men reported that their families in Mexico were poor. Men who reported U.S. injection initiation were significantly less likely to be employed in Mexico pre-migration and more likely to have ever used non-injected drugs pre-migration. Overall, half of men consumed alcohol and a third reported any drug use pre-migration.

Table I.

Selected Factors Associated with U.S. Injection Initiation Among Deported Male IDUs in the Quantitative (N = 309) and Qualitative (N = 23) Sub-Studies in Tijuana, Mexico, 2010

QUANTITATIVE SAMPLE QUALITATIVE
SAMPLE
Full
Sample
(n, %)
Initiated
Injection
in the
U.S.
(n=114;
37%)
Did Not
Initiate
Injection
in the
U.S.
(n=195;
63%)
χ2 (P-
value)
RDS-
Adjusted
Univariate
Odds
Ratio
RDS-
Adjusted
95%
Confidence
Interval
(n, %) a
Pre-Migration (Mexico) Context & Socio-Demographics
Median age a, b (interquartile
range; IQR)
39 (34–44) 37 (32–
43)
39 (34–
44)
1.683
(.092)
1.00 0.94–1.06 40 (33–44)
Born in Tijuana 72 (23) 35 (31) 37 (19) 5.536
(.019)
1.83 0.56–5.93 2 (9)
Family in Mexico was poor 212 (69) 71 (62) 141 (72) 3.358
(.067)
0.35 0.14–0.85 11 (48)
Median highest year of
education completed in
Mexico (IQR) b
6 (4–9) 5 (0–7) 6 (6–9) 5.476
(<.001)
0.77 0.67–0.89 6 (3–8)
Employed in Mexico pre-
migration
207 (67) 56 (49) 151 (77) 26.080
(<.001)
0.17 0.07–0.42 17 (74)
Ever consumed alcohol in
Mexico pre-migration
157 (51) 55 (48) 102 (52) .475
(.491)
0.55 0.23–1.33 13 (57)
Ever consumed any drugs in
Mexico pre-migration
95 (31) 49 (43) 46 (24) 12.707
(<.001)
1.28 0.51–3.19 11 (48)
 Consumed marijuana c 89 (94) 47 (96) 42 (91) .853
(.356)
1.31 0.52–3.31 9 (39)
 Consumed inhalants
(glue) c
30 (32) 20 (41) 10 (22) 3.996
(.046)
2.23 0.57–8.73 2 (9)
Saw family members in
Mexico consuming drugs
pre-migration
45 (15) 20 (18) 25 (13) 1.290
(.256)
0.65 0.24–1.76 3 (13)
Knew people involved in
drug trade in Mexico pre-
migration
90 (29) 39 (34) 51 (26) 2.262
(.133)
0.85 0.38–1.90 2 (9)
Initial U.S. Migration Experiencesd
Median age independent
from family (IQR) b
17 (15–18) 16 (14–
17)
17 (15–
18)
5.192
(<.001)
0.87 0.75–1.10 16 (14–18)
Median age at first U.S.
migration (IQR) in years b
17 (13–19) 15 (3–
17)
17 (15–
20)
5.909
(<.001)
0.84 0.78–0.91 17 (12–18)
Migrated in search of better
economic opportunities
211 (68) 60 (53) 151 (77) 20.438
(<.001)
0.27 0.10–0.72 16 (70)
Migrated with parent(s) 92 (30) 49 (43) 43 (22) 15.074
(<.001)
4.72 1.55–14.40 4 (17)
Migrated with sibling(s) 87 (28) 29 (25) 58 (30) .6591
(.417)
1.50 0.45–5.06 6 (26)
Migrated with friend(s) 173 (56) 53 (46) 120 (62) 6.610
(.010)
0.19 0.08–0.44 12 (52)
Migrated with smuggler (e.g.,
coyote)
57 (18) 15 (13) 42 (22) 3.359
(.067)
0.58 0.21–1.58 2 (9)
Post-Migration (U.S.) Context
Already knew people living
in U.S. d
237 (78) 73 (66) 164 (85) 13.491
(<.001)
0.75 0.28–2.04 17 (74)
Lived in California, vs. all
other U.S. states d
305 (99) 112 (98) 193 (99) 0.299
(.585)
2.76 0.94–8.12 21 (91)
Median total years living in
U.S. (IQR) a, b
13 (10–17) 15 (10–
22)
12 (10–
15)
−3.929
(<.001)
1.12 1.03–1.21 14 (8–20)
Ever incarcerated in U.S. 203 (66) 104 (91) 99 (51) 52.254
(<.001)
8.35 2.05–34.00 16 (70)
Median years incarcerated
U.S. (IQR) b, e
2 (1–5) 2.5 (1.5–
5)
1.5 (0.4–
4)
−3.660
(<.001)
1.02 0.88–1.19 3 (1–6)
Ever accessed drug
treatment services in the U.S.
5 (2) 3 (3) 2 (1) 1.166
(.280)
2.61 0.43–15.84 1 (4)
a

Data are from quantitative surveys conducted between January and April, 2010.

b

Test statistic is z-score for Wilcoxon rank-sum test.

c

Among those who ever consumed drugs in Mexico pre-migration (n = 95).

d

Refers to experiences surrounding first U.S. migration.

e

Among those who were ever incarcerated in the United States (n = 203).

Second, regarding initial U.S. migration experiences, many men reported becoming independent from their families during adolescence, and younger age at first migration was significantly associated with U.S. injection initiation in univariate analyses. Men who migrated in search of better economic opportunities were less likely to report U.S. injection initiation, while those who migrated with at least one parent were more likely to initiate injection in the United States.

Third, in the post-migration U.S. context, nearly all men resided in California. Men who already knew someone in the United States at the time of their first U.S. migration were less likely to report U.S. injection initiation. Increasing duration of total U.S. residence and ever being incarcerated were associated with U.S. injection initiation. Overall, the most common drugs men reported ever using in the United States included marijuana (82%), cocaine (70%), heroin (56%), and crack (36%; data not shown). Among men reporting U.S. injection, 78% ever injected heroin and 45% ever injected cocaine (data not shown). Very few men reported receiving any drug treatment in the United States.

Table II presents results from our final, RDS-adjusted multivariable logistic regression model that identified three factors independently associated with U.S. injection initiation: ever consuming any drugs in Mexico pre-migration, younger age at first U.S. migration, and U.S. incarceration. No significant confounders or interactions were identified.

Table II.

Quantitative and Qualitative Findings Regarding U.S. Injection Initiation Among Deported Male IDUs in Tijuana, Mexico (2008 – 2010)

QUANTITATIVE RESULTS QUALITATIVE RESULTS
Context
from
Theoretical
Framework
Variable RDS-Adjusted
AOR a
(95% CI) b
Theme Illustrative Quotes
1. Pre-
Migration
(Mexico)
Context
Ever
consumed
any drugs in
Mexico pre-
migration
4.61
(2.36–9.00)
Limited drug use in
Mexico pre-migration:
  • Some exposure to illicit drugs by families, schools, communities

  • Social pressure against drug use

There in Sonora, they’ve always had heroin. Since I was a kid, I
saw tecatos [junkies; IDUs]; I saw drugs. I had an uncle who died
of an overdose when I was just a kid. –first migrated at age 17


I started to smoke [marijuana], very hidden. I remember well that
I was just a kid. […] I would hide it in my socks or other places
so they wouldn’t find it in the house. –first migrated at age 14
2. Initial
U.S.
Migration
Experiences
Age first
migrated to
U.S. (per
year
increase)
0.86
(0.82–0.89)
-- --
3. Post-
Migration
(U.S.)
Context
Ever
incarcerated
in United
States
6.00
(2.84–12.68)
U.S. criminal records
were intertwined with
drug abuse:
  • Early delinquency related to drug use

  • Crimes relating to drugs (possession, paraphernalia)

  • Poor access to drug treatment (immigration status)

  • Coping with guilt/emotions from criminal activities

Because sometimes I couldn’t earn enough money, well, I would
go out to make mischief, rob or sell drugs. It wasn’t an honest
way to live. Then, because I was selling drugs and doing bad
things to survive, so that I wouldn’t run out of drugs, they caught
me and … and sent me the first time to [juvenile hall] and then to
prison. […] There were a lot of tecatos [junkies; IDUs] in there.
–first migrated at age 12


I went to pick up some heroin, and that’s when they caught me. I
had malilla [withdrawal], and I was going to find a syringe … A
patrol car passed by and they saw me … I think someone must
have pointed me out, because when I started running, they already
had me … they caught me with the drugs. –first migrated at age 3


I did time [in] a [drug] rehabilitation center. I was in the
program for like eight months, and my counselor found out that I
got an immigration hold. So they told me that I can’t keep with the
program because I got to be deported. And so they threw me out.
–first migrated at age 17


I was initiated into a gang over there with my cousins. […]
Using drugs, I wouldn’t have a guilty conscience if I hit someone,
hurt someone, that is, it wouldn’t bother me who it was. That’s the
reason why I started using more drugs: to believe myself to be
superior to the others. –first migrated at age 8
-- -- Importance of U.S.
social context:
  • Social networks facilitated first injection; friends, family, neighbors helped inject

  • Girlfriends/sex partners helped initiate; inject to impress women

  • Social networks reduced barriers to injecting (e.g., fear of syringes, low knowledge)

  • Drug abuse, injection, selling were pervasive in social networks

  • Social pressure to inject; blaming of friends for negatively influencing drug abuse trajectories

I started because of my neighbors who were already injecting. I
didn’t know that it was heroin. I just saw that they were mixing
something with cocaine and they offered me some … They told
me, “Think about it, because this is strong.” […] That’s how I
started injecting, and I liked it. –first migrated at age 12


There were several of us there, and I liked this girl … one time
she suddenly asked me, “Do you want some [heroin]?” And in
order to look good, I said, “Sure,” and she said, “Put out your
arm,” and she injected me, and that was the first time I tried
heroin. […] I started to vomit, sweat, and after all of that
passed, well, I liked it… I told her that I would like more… and
that’s how I started using. –first migrated at age 19


I was with some friends of mine, and they doctored me up, you
know, a few times. I was kind of scared by the needle, but after
they helped me get used to seeing it, I started using every three or
four days. –first migrated at age 17


When I was there, [cocaine] was all I was seeing all day, you
know what I mean? I saw everyone doing it. I just kept using it,
and after a little while, I got addicted. […] My friends were kind
of drug dealers and I didn’t have to pay for it, so it was easy for
me to get it. Sometimes they’d just tell me, “Go ahead, use it if
you want to.” “I don’t have a pipe.” “So just slam [inject] it,”
you know what I mean? –first migrated at age 11


I didn’t want to inject because … I had my job, I had my
apartment. I was doing well … the thing that did me the most
harm was my friends … My friends really derailed me. –first
migrated at age 24
a

Adjusted odds ratios from multivariable logistic regression model; adjusted for RDS sampling method.

b

Confidence Interval; all variables significant at P ≤ 0.001.

Qualitative Findings

Table I also presents socio-demographics and migration characteristics for the 23 men included in our qualitative analysis. In the United States, men reported consuming cocaine (61%), marijuana (52%), heroin (43%), and crack (22%; data not shown). We identified three broad themes in the qualitative interviews relating to U.S. injection initiation. The first two themes helped contextualize two of our multivariable logistic regression results: pre-migration drug use in Mexico, and U.S. incarceration. The third theme that emerged from our qualitative analysis was the importance of social contexts surrounding U.S. injection initiation. These themes are described below, and illustrative quotes are provided in Table II.

Pre-Migration Drug Use in Mexico

Qualitative data helped contextualize our first quantitative finding that ever consuming any drugs in Mexico pre-migration was independently associated with U.S. injection initiation. In qualitative interviews, men who reportedly consumed drugs before their first U.S. migration described a high prevalence of drug abuse in their families, schools, and communities in Mexico although they only occasionally consumed alcohol and/or marijuana themselves. In contrast, drug abuse was not accepted or condoned in all families or communities: non-drug using participants described social pressure against substance use within their families and communities in Mexico, with one man attempting to hide drugs from parents during adolescence.

U.S. Incarceration

Passages from qualitative interviews also helped clarify our quantitative finding that men reporting U.S. incarceration were nearly six times more likely to report U.S. injection initiation. As described in interviews, once incarcerated, most men who reported U.S. injection initiation were already injecting drugs. Interview texts revealed that men’s lengthy U.S. criminal histories began in adolescence or early adulthood and were intertwined with escalating drug abuse and related social and family problems, including running away from home. Many men with lengthy criminal records reported being arrested at least once for drug-related crimes, including drug or paraphernalia possession charges. Men were also arrested for crimes indirectly related to their drug abuse, such as drug selling or theft to earn money for drugs. Despite acute withdrawal that some men reported experiencing in prison, drug treatment services were generally unavailable. One man reported that although he was sent to a court-mandated U.S. drug treatment program, he was returned to prison to await deportation upon discovery of his migration status.

Social Contexts of U.S. Injection Initiation

While our quantitative survey did not fully capture the social environment under which injection occurred, men who participated in qualitative interviews emphasized and elaborated upon the social contexts surrounding their U.S. drug abuse. For many men (n = 14), U.S. social networks were central in descriptions of first injection experiences. Ten men described U.S. injection initiation occurring with close friends, family and neighbors who often provided men with help injecting. Four men described injection initiation as occurring with girlfriends and sexual partners. One man reported that his girlfriend was already injecting when she introduced him to drugs, so he never used other routes of administration (e.g., smoking or snorting). Another man started injecting at a party where he wanted to impress a woman.

Men’s U.S. social networks reduced barriers to injecting drugs (e.g., apprehension or fear of syringes or not knowing how to inject). Starting in high school in the United States, some men frequently attended parties where drugs were present. Friends provided drugs and injection equipment, and exposure to drug selling. Although some men described curiosity about the drugs used by friends who eventually enabled their own injection initiation, others described stronger social pressure to inject and even placed blame on friends for negatively influencing them or encouraging their escalating drug abuse. Transitions to injection also occurred for practical reasons, including coping with increasing physical dependence, seeking a stronger effect or more efficient route of administration, and trying to stay awake for long work shifts. One man described using drugs to cope with guilt and other emotional effects resulting from his criminal activities.

DISCUSSION

This mixed-methods study extends previous research on deported male IDUs’ drug abuse trajectories [17] by quantifying statistical associations with a larger study population and contextualizing U.S. injection initiation using data from men’s qualitative interviews. Our quantitative survey revealed that over one-third of deported male IDUs first injected drugs while living as undocumented migrants in the United States. U.S. injection initiation was independently associated with ever consuming drugs in Mexico pre-migration, being younger at first migration, and ever being incarcerated in the United States. Qualitative interviews with a subset of deportees contextualized two of these three quantitative findings (pre-migration drug use and U.S. incarceration), and an additional theme emerged regarding the importance of social contexts surrounding first injection experiences in the United States. Findings from our study emphasize the influence of changing risk environments on undocumented migrants’ drug abuse trajectories in several ways.

First, we found qualitative and quantitative evidence that pre-migration circumstances and initial migration experiences may shape migrants’ early drug use behaviors, as posited in our theoretical framework. We found quantitative support for our hypothesis that pre-migration drug use would be positively associated U.S. injection initiation. Since the majority of our quantitative sample did not migrate with parents, any pre-migration parental monitoring and social pressure against drug use may have also declined with initial U.S. migration. Quantitative data further revealed that younger age at first U.S. migration was associated with U.S. injection initiation: on average, men migrated at approximately 16 years of age. Taken together, our qualitative data regarding the pre-migration period suggest ways in which pre-migration drug use and younger age at first migration may lead to U.S. injection initiation. For example, unaccompanied migrant youths may be vulnerable to drug initiation or continued use following migration to U.S. communities where drug abuse, injection practices, and deviant or delinquent behaviors are normative [8]. Additional research is needed to fully elucidate the social/familial and drug use climates experienced by undocumented migrant youths.

Our qualitative findings emphasize the importance of the social risk environment in influencing undocumented U.S. migrants’ drug abuse trajectories. This social context was not fully captured in our quantitative data, and qualitative methods may be better suited for exploring broad social processes and contexts (e.g., how injection may be learned through one’s social network), as well as understanding the meanings that individuals attach to social phenomena [61, 66]. Men’s qualitative interviews revealed the social nature of first injection experiences and confirmed previous research findings that injection drug use is a learned behavior requiring facilitation through social relationships and depending on the social environment in which potential injection initiates reside [48]. Qualitative interviews indicated that men often required injection assistance for their first injection event(s), a practice that has been associated with elevated risk of HIV seroconversion [67] and receptive syringe sharing in Tijuana [68] and internationally [69, 70]. Research has also identified social processes (e.g., spending time with friends or sexual partners who inject drugs) that render injecting acceptable and even appealing to non-injectors [50]. This social network influence and facilitation of injection initiation has been found in other settings [32, 42], including among Mexican American heroin users in Texas [8, 52], where high rates of injection initiation are of particular concern [53]. Men in our sample reported already spending time within drug using social networks when they were presented with opportunities to begin injecting. Additional research is needed to identify factors that facilitate involvement in drug-using social networks or inhibit time spent within such networks, including the positive (i.e., anti-drug) social norms within migrant communities [47, 71].

Finally, our quantitative finding that U.S. incarceration was associated with increased odds of U.S. injection initiation supported our theoretical framework’s emphasis on the importance of the physical risk environment [55] in shaping undocumented migrants’ drug abuse [56]. Although we cannot determine the temporality of U.S. injection initiation in relation to incarceration events from our quantitative data, our mixed methods approach helped illuminate social contexts and processes surrounding injection initiation and incarceration. In qualitative interviews, men explained how increasing drug abuse, dependence, and injection contributed to their engagement in delinquent and criminal behaviors, suggesting that U.S. injection initiation likely occurred in the community before, and possibly led to, incarceration. As in the general population of U.S. prisoners, illegal drug seeking and drug-related behaviors contributed to male deportees’ lengthy criminal records [72].

Our findings regarding U.S. incarceration and injection initiation are concerning given international evidence linking incarceration to risky injection behaviors and increased risk of blood borne infections, particularly among new (i.e., recently initiated) IDUs [73, 74]. Although more than one third of drug-dependent U.S. prisoners access drug treatment services while incarcerated [72], few men in our study (<2%) reported receiving any drug treatment services during their entire U.S. residence, and one man was removed from a court-mandated drug treatment due to his undocumented migration status. Despite recommendations regarding the treatment of drug abuse and addiction within the criminal justice system [75], our findings indicate an unmet need for drug treatment services for incarcerated migrants during incarceration and deportation, and following release.

Our study yields implications for interventions to prevent injection initiation, for which several models exist [32, 48, 76]. Since preventing or delaying injection initiation requires reaching drug users earlier in their drug careers [33, 36], our findings suggest that programs should reach immigrant, including undocumented, youth before they progress to frequent drug use and delinquent behaviors. Community-based participatory research and other strategies for reaching undocumented populations [54] could help identify ways to adapt promising existing interventions such as Familias Unidas [United Families], a parent-centered intervention to reduce adolescent substance abuse and other behavior problems in poor immigrant Hispanic families [77, 78]. We also found that injection initiation occurred in highly social environments (e.g., neighborhood parties), implying that interventions should identify and leverage positive social or cultural norms that discourage injecting [47, 71]. Existing models to promote the successful community reentry of drug abusing parolees should be adapted for migrants [79]. These models should also be extended to deported individuals facing significant unmet need for drug treatment, a problem that may be compounded by the worsened economic and legal vulnerabilities that follow deportation [17]. Within the post-deportation environment in Mexico, HIV prevention programs could draw from innovative harm reduction approaches to reducing drug-related harm, including peer education and outreach models [71].

Our study was limited by several factors. First, we relied on self-report of sensitive migration and drug-related behaviors. However, our use of trained interviewers known to the study population should have reduced social desirability bias. A second limitation was our reliance on recall of past events using quantitative and qualitative instruments that were conducted approximately two years apart, implying a possibility of inconsistency. However, there is evidence that drug users can accurately recall early and significant drug use and life events [80]. Third, due to the length and complexity of migration trajectories, we asked men to focus on their “most recent deportation” and consequently lacked detailed data regarding injection initiation for persons who initiated outside of the United States. Nevertheless, our mixed methods approach allowed us to disentangle the temporal nature of certain contexts (e.g., drug abuse and criminal trajectories). Finally, our study drew from a specific population of deported male IDUs residing in Tijuana and our findings cannot be generalized to broader populations of deported individuals in Mexico or undocumented migrants in the United States. However, given the paucity of data on drug abuse among undocumented migrants, we feel that our involvement with a unique a group of high risk deportees provides important and rare insight into the undocumented experience.

Our use of multiple sources of data enabled us to more thoroughly understand the epidemiology and contexts of U.S. injection initiation among a sample of deported IDUs who lacked documented status in the United States. Additional research is needed to further contextualize the injection careers of migrant IDUs who initiated injection outside of the United States (i.e., pre- or post-deportation). We also recommend further research to identify strategies to reach other high risk, migrant drug users including women and non-injecting deportees who may be at risk of post-deportation injection initiation or other escalations in drug abuse. Our findings imply an unmet need for drug treatment and other health and social services for drug abusing migrants on both sides of the U.S.-Mexico border. Given the strong associations with public health harms, including transmission of HIV and other blood borne infections, delinquency and incarceration, preventing injection initiation should become a binational priority.

Acknowledgements

This research was supported by the UCSD Academic Senate (RI296H-OJEDA), the University of California HIV/AIDS Research Program (ID08-SD-073), and the National Institute on Drug Abuse (K01DA025504, K01DA022923, R01DA019829, T32DA023356 and R36DA032376). The authors gratefully acknowledge the contributions of study participants and staff at Pro-COMUSIDA, PrevenCasa and UCSD for assistance with data collection.

REFERENCES

  • 1.Centers for Disease Control and Prevention . HIV among Hispanics/Latinos [Internet] U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; Atlanta: [Accessed November 30, 2011]. 2009. Available from: http://www.cdc.gov/hiv/hispanics/index.htm. [Google Scholar]
  • 2.Cheung R. Chronic hepatitis C in the Hispanic population [Internet] Hepatitis C Support Project, HCV Advocate Medical Writers Circle; San Francisco: [Accessed November 30, 2011]. 2006. Available from: http://www.hcvadvocate.org/hcsp/articles/hispanics.html. [Google Scholar]
  • 3.Tedaldi EM, Hullsiek KH, Malvestutto CD, et al. Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on AIDS. Clin Infect Dis. 2003 May;36(10):1313–7. doi: 10.1086/374841. [DOI] [PubMed] [Google Scholar]
  • 4.Grant BF, Stinson FS, Hasin DS, Dawson DA, Chou SP, Anderson K. Immigration and lifetime prevalence of DSM-IV psychiatric disorders among Mexican Americans and non-Hispanic whites in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004 Dec;61(12):1226–33. doi: 10.1001/archpsyc.61.12.1226. [DOI] [PubMed] [Google Scholar]
  • 5.Magis-Rodriguez C, Gayet C, Negroni M, et al. Migration and AIDS in Mexico: an overview based on recent evidence. J Acquir Immune Defic Syndr. 2004;(37 Suppl 4):S215–26. doi: 10.1097/01.qai.0000141252.16099.af. [DOI] [PubMed] [Google Scholar]
  • 6.Magis-Rodriguez C, Lemp G, Hernandez MT, Sanchez MA, Estrada F, Bravo-Garcia E. Going North: Mexican migrants and their vulnerability to HIV. J Acquir Immune Defic Syndr. 2009 May;(51 Suppl 1):S21–5. doi: 10.1097/QAI.0b013e3181a26433. [DOI] [PubMed] [Google Scholar]
  • 7.Chavez LR. Shadowed lives: undocumented immigrants in American society. 2nd ed Wadsworth; Belmont: 1998. p. 240. [Google Scholar]
  • 8.Valdez A, Cepeda A. The relationship of ecological containment and heroin practices. In: Thomas YF, Richardson D, Cheung I, editors. Geography and drug addiction. Springer; Dordrecht (Netherlands): 2008. pp. 159–73. [Google Scholar]
  • 9.Arbona C, Olvera N, Rodriguez N, Hagan J, Linares A, Wiesner M. Acculturative stress among documented and undocumented Latino immigrants in the United States. Hisp J Behav Sci. 2010;32(3):362–84. doi: 10.1177/0739986310373210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Apostolopoulos Y, Sonmez S, Kronenfeld J, Castillo E, McLendon L, Smith D. STI/HIV risks for Mexican migrant laborers: exploratory ethnographies. J Immigr Minor Health. 2006 Jul;8(3):291–302. doi: 10.1007/s10903-006-9334-2. [DOI] [PubMed] [Google Scholar]
  • 11.Brouwer KC, Lozada R, Cornelius WA, et al. Deportation along the U.S.-Mexico border: its relation to drug use patterns and accessing care. J Immigr Minor Health. 2009 Feb;11(1):1–6. doi: 10.1007/s10903-008-9119-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Strathdee SA, Lozada R, Ojeda VD, et al. Differential effects of migration and deportation on HIV infection among male and female injection drug users in Tijuana, Mexico. PLoS One. 2008;3(7):e2690. doi: 10.1371/journal.pone.0002690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Department of Homeland Security . 2009 Yearbook of Immigration Statistics [Internet] Department of Homeland Security, Office of Immigration Statistics; Washington, D.C.: [Accessed November 30, 2011]. 2010. Available from: http://www.dhs.gov. [Google Scholar]
  • 14.Slevin P. Deportation of illegal immigrants increases under Obama administration. The Washington Post. 2010 Jul 26; Sect.A:01. [Google Scholar]
  • 15.Department of Homeland Security . INA: ACT 212: General clauses of aliens ineligible to receive visas and ineligible for admission; waivers of inadmissibility [Internet] Department of Homeland Security, Office of Citizenship and Immigration Services; Washington, D.C.: [Accessed November 30, 2011]. 2001. Available from: http://www.uscis.gov. [Google Scholar]
  • 16.National Migration Institute . Monthly bulletin of migration statistics 2010: repatriation of Mexicans from the United States; Internet. Secretaria de Gobernacion, Insituto Nacional de Migracion; Mexico, D.F. (Mexico): [Accessed November 30, 2011]. 2010. Available from: http://www.inm.gob.mx. [Google Scholar]
  • 17.Ojeda VD, Robertson AM, Hiller SP, et al. A qualitative view of drug use behaviors of Mexican male injection drug users deported from the United States. J Urban Health. 2011 Feb;88(1):104–17. doi: 10.1007/s11524-010-9508-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.National Institute of Statistics and Geography . Population and Housing Census 2010; Internet. Instituto Nacional de Estadística y Geographía; Mexico, D.F. (Mexico): [Accessed November 30, 2011]. 2011. Available from: http://www.censo2010.org.mx. [Google Scholar]
  • 19.Bucardo J, Brouwer KC, Magis-Rodriguez C, et al. Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood borne infections. Drug Alcohol Depend. 2005 Sep;79(3):281–93. doi: 10.1016/j.drugalcdep.2005.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Brouwer KC, Case P, Ramos R, et al. Trends in production, trafficking, and consumption of methamphetamine and cocaine in Mexico. Subst Use Misuse. 2006;41(5):707–27. doi: 10.1080/10826080500411478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Strathdee SA, Fraga WD, Case P, et al. “Vivo para consumirla y la consumo para vivir” [“I live to inject and inject to live”]: high-risk injection behaviors in Tijuana, Mexico. J Urban Health. 2005 Sep;82(3 Suppl 4):iv58–73. doi: 10.1093/jurban/jti108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;(18 Suppl 1):11–9. doi: 10.1097/00042560-199802001-00004. [DOI] [PubMed] [Google Scholar]
  • 23.Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health. 1996 May;86(5):655–61. doi: 10.2105/ajph.86.5.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Van Ameijden EJ, Van den Hoek JA, Mientjes GH, Coutinho RA. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur J Epidemiol. 1993 May;9(3):255–62. doi: 10.1007/BF00146260. [DOI] [PubMed] [Google Scholar]
  • 25.Hahn JA, Page-Shafer K, Lum PJ, Ochoa K, Moss AR. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology. 2001 Jul;34(1):180–7. doi: 10.1053/jhep.2001.25759. [DOI] [PubMed] [Google Scholar]
  • 26.Thorpe LE, Ouellet LJ, Levy JR, Williams IT, Monterroso ER. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. J Infect Dis. 2000 Dec;182(6):1588–1594. doi: 10.1086/317607. [DOI] [PubMed] [Google Scholar]
  • 27.Chang CJ, Lin CH, Lee CT, Chang SJ, Ko YC, Liu HW. Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan. Eur J Epidemiol. 1999 Aug;15(7):597–601. doi: 10.1023/a:1007662315835. [DOI] [PubMed] [Google Scholar]
  • 28.Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D. Correlates of HIV infection among young adult short-term injection drug users. AIDS. 2000 Apr;14(6):717–26. doi: 10.1097/00002030-200004140-00011. [DOI] [PubMed] [Google Scholar]
  • 29.Miller CL, Johnston C, Spittal PM, et al. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology. 2002 Sep;36(3):737–42. doi: 10.1053/jhep.2002.35065. [DOI] [PubMed] [Google Scholar]
  • 30.van Beek I, Dwyer R, Dore GJ, Luo K, Kaldor JM. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ. 1998 Aug;317(7156):433–7. doi: 10.1136/bmj.317.7156.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Rezza G, Sagliocca L, Zaccarelli M, Nespoli M, Siconolfi M, Baldassarre C. Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence. Scand J Infect Dis. 1996;28(1):27–9. doi: 10.3109/00365549609027145. [DOI] [PubMed] [Google Scholar]
  • 32.Des Jarlais DC, Casriel C, Friedman SR, Rosenblum A. AIDS and the transition to illicit drug injection--results of a randomized trial prevention program. Br J Addict. 1992 Mar;87(3):493–8. doi: 10.1111/j.1360-0443.1992.tb01950.x. [DOI] [PubMed] [Google Scholar]
  • 33.Goldsamt LA, Harocopos A, Kobrak P, Jost JJ, Clatts MC. Circumstances, pedagogy and rationales for injection initiation among new drug injectors. J Community Health. 2010 Jun;35(3):258–67. doi: 10.1007/s10900-010-9231-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Sherman SG, Cheng Y, Kral AH. Prevalence and correlates of opiate overdose among young injection drug users in a large U.S. city. Drug Alcohol Depend. 2007 May;88(2-3):182–7. doi: 10.1016/j.drugalcdep.2006.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Fennema JS, Van Ameijden EJ, Van Den Hoek A, Coutinho RA. Young and recent-onset injecting drug users are at higher risk for HIV. Addiction. 1997 Nov;92(11):1457–65. [PubMed] [Google Scholar]
  • 36.Vlahov D, Fuller CM, Ompad DC, Galea S, Des Jarlais DC. Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health. 2004 Mar;81(1):14–9. doi: 10.1093/jurban/jth083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Fuller CM, Borrell LN, Latkin CA, et al. Effects of race, neighborhood, and social network on age at initiation of injection drug use. Am J Public Health. 2005 Apr;95(4):689–95. doi: 10.2105/AJPH.2003.02178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Fuller CM, Vlahov D, Arria AM, Ompad DC, Garfein R, Strathdee SA. Factors associated with adolescent initiation of injection drug use. Public Health Rep. 2001;(116 Suppl 1):136–45. doi: 10.1093/phr/116.S1.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Fuller CM, Vlahov D, Latkin CA, Ompad DC, Celentano DD, Strathdee SA. Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young adult injection drug users. J Acquir Immune Defic Syndr. 2003 Jan;32(1):86–93. doi: 10.1097/00126334-200301010-00013. [DOI] [PubMed] [Google Scholar]
  • 40.Fuller CM, Vlahov D, Ompad DC, Shah N, Arria A, Strathdee SA. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend. 2002 Apr;66(2):189–98. doi: 10.1016/s0376-8716(01)00200-9. [DOI] [PubMed] [Google Scholar]
  • 41.Neaigus A, Gyarmathy VA, Miller M, Frajzyngier VM, Friedman SR, Des Jarlais DC. Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr. 2006 Apr;41(4):493–503. doi: 10.1097/01.qai.0000186391.49205.3b. [DOI] [PubMed] [Google Scholar]
  • 42.Neaigus A, Miller M, Friedman SR, et al. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction. 2001 Jun;96(6):847–60. doi: 10.1046/j.1360-0443.2001.9668476.x. [DOI] [PubMed] [Google Scholar]
  • 43.Roy E, Haley N, Leclerc P, Cedras L, Blais L, Boivin JF. Drug injection among street youths in Montreal: predictors of initiation. J Urban Health. 2003 Mar;80(1):92–105. doi: 10.1093/jurban/jtg092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Sanchez J, Chitwood DD, Koo DJ. Risk factors associated with the transition from heroin sniffing to heroin injection: a street addict role perspective. J Urban Health. 2006 Sep;83(5):896–910. doi: 10.1007/s11524-006-9059-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Hamid A, Curtis R, McCoy K, et al. The heroin epidemic in New York City: current status and prognoses. J Psychoactive Drugs. 1997 Oct-Dec;29(4):375–91. doi: 10.1080/02791072.1997.10400565. [DOI] [PubMed] [Google Scholar]
  • 46.Ciccarone D. Heroin in brown, black and white: structural factors and medical consequences in the US heroin market. Int J Drug Policy. 2009 May;20(3):277–82. doi: 10.1016/j.drugpo.2008.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Small W, Fast D, Krusi A, Wood E, Kerr T. Social influences upon injection initiation among street-involved youth in Vancouver, Canada: a qualitative study. Subst Abuse Treat Prev Policy. 2009 Apr;4:8. doi: 10.1186/1747-597X-4-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Sherman SG, Smith L, Laney G, Strathdee SA. Social influences on the transition to injection drug use among young heroin sniffers: a qualitative analysis. Int J Drug Policy. 2002;13:113–20. [Google Scholar]
  • 49.Lankenau SE, Wagner KD, Bloom J Jackson, Sanders B, Hathazi D, Shin C. The first injection event: differences among heroin, methamphetamine, cocaine, and ketamine initiates. J Drug Issues. 2010 Spring;40(2):241–62. doi: 10.1177/002204261004000201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Harocopos A, Goldsamt LA, Kobrak P, Jost JJ, Clatts MC. New injectors and the social context of injection initiation. Int J Drug Policy. 2009 Jul;20(4):317–23. doi: 10.1016/j.drugpo.2008.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.van Ameijden EJ, van den Hoek JA, Hartgers C, Coutinho RA. Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. Am J Epidemiol. 1994 Jun;139(12):1153–63. doi: 10.1093/oxfordjournals.aje.a116962. [DOI] [PubMed] [Google Scholar]
  • 52.Valdez A, Cepeda A, Neaigus A, Russell A. Heroin transition risk among daily and non-daily cannabis users who are non-injectors of heroin. Int J Drug Policy. 2008 Dec;19(6):442–9. doi: 10.1016/j.drugpo.2007.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Valdez A, Neaigus A, Kaplan C, Cepeda A. High rates of transitions to injecting drug use among Mexican American non-injecting heroin users in San Antonio, Texas (never and former injectors) Drug Alcohol Depend. 2011 Apr;114(2-3):233–6. doi: 10.1016/j.drugalcdep.2010.09.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Cornelius WA. Interviewing undocumented immigrants: methodological reflections based on fieldwork in Mexico and the US. International Migration Review. 1982;16(2):378. [PubMed] [Google Scholar]
  • 55.Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy. 2009 May;20(3):193–201. doi: 10.1016/j.drugpo.2008.10.003. [DOI] [PubMed] [Google Scholar]
  • 56.Gil AG, Vega WA. Latino Drug Use: scope, risk factors, and reduction strategies. In: Aguirre-Molina M, Molina CW, Zambrana RE, editors. Health Issues in the Latino Community. Jossey-Bass; San Francisco: 2001. pp. 436–40. [Google Scholar]
  • 57.Strathdee SA, Lozada R, Pollini RA, et al. Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico. J Acquir Immune Defic Syndr. 2008 Mar;47(3):369–76. doi: 10.1097/QAI.0b013e318160d5ae. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Heckathorn D. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174–99. [Google Scholar]
  • 59.Abramovitz D, Volz EM, Strathdee SA, Patterson TL, Vera A, Frost SD. Using respondent-driven sampling in a hidden population at risk of HIV infection: who do HIV-positive recruiters recruit? Sex Transm Dis. 2009 Dec;36(12):750–6. doi: 10.1097/OLQ.0b013e3181b0f311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Creswell JW, Clark VL Plano, Gutmann ML, Hanson WE. Advanced mixed methods research designs. In: Tashakkori A, Teddlie CB, editors. Handbook of mixed methods in social & behavioral research. Sage Publications; Thousand Oaks: 2003. pp. 209–40. [Google Scholar]
  • 61.Creswell JW, Clark VL Plano. Designing and conducting mixed methods research. Sage Publications; Thousand Oaks: 2007. p. 296. [Google Scholar]
  • 62.Volz E, Wejnert C, Degani I. Respondent-Driven Sampling Analysis Tool (RDSAT) version 5.6 Cornell University; Ithaca: 2007. [Google Scholar]
  • 63.Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59–82. [Google Scholar]
  • 64.Muhr T. ATLAS.ti. version 5.0 Scientific Software; Berlin (Germany): 2005. [Google Scholar]
  • 65.Onwuegbuzie AJ, Teddlie C. A framework for analyzing data in mixed methods resarch. In: Tashakkori A, Teddlie CB, editors. Handbook of mixed methods in social and behavioral research. Sage Publications; Thousand Oaks: 2003. pp. 351–83. [Google Scholar]
  • 66.Wagner KD, Davidson PJ, Pollini RA, Strathdee SA, Washburn R, Palinkas LA. Reconciling incongruous qualitative and quantitative findings in mixed methods research: exemplars from research with drug using populations. Int J Drug Policy. doi: 10.1016/j.drugpo.2011.05.009. Epub 2011 Jun 14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.O’Connell JM, Kerr T, Li K, et al. Requiring help injecting independently predicts incident HIV infection among injection drug users. J Acquir Immune Defic Syndr. 2005 Sep;40(1):83–8. doi: 10.1097/01.qai.0000157006.28535.ml. [DOI] [PubMed] [Google Scholar]
  • 68.Robertson AM, Vera AY, Gallardo M, et al. Correlates of seeking injection assistance among injection drug users in Tijuana, Mexico. Am J Addict. 2010 Jul-Aug;19(4):357–63. doi: 10.1111/j.1521-0391.2010.00053.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Kral AH, Bluthenthal RN, Erringer EA, Lorvick J, Edlin BR. Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction. 1999 May;94(5):675–83. doi: 10.1046/j.1360-0443.1999.9456755.x. [DOI] [PubMed] [Google Scholar]
  • 70.Wood E, Spittal PM, Kerr T, et al. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention. Can J Public Health. 2003 Sep-Oct;94(5):355–9. doi: 10.1007/BF03403560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Latkin CA. Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users’ networks. Public Health Rep. 1998 Jun;(113 Suppl 1):151–9. [PMC free article] [PubMed] [Google Scholar]
  • 72.Mumola CJ, Karberg JC. Drug Use and Dependence, State and Federal Prisoners, 2004 [Internet] Department of Justice, Office of Justice Programs, Bureau of Justice Statistics; Washington, D.C.: [Accessed November 30, 2011]. 2006. Available from: http://bjs.ojp.usdoj.gov/content/pub/pdf/dudsfp04.pdf. [Google Scholar]
  • 73.Cheng Y, Sherman SG, Srirat N, et al. Risk factors associated with injection initiation among drug users in Northern Thailand. Harm Reduct J. 2006 Mar;3:10. doi: 10.1186/1477-7517-3-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Clatts MC, Colon-Lopez V, le M Giang, Goldsamt LA. Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection. J Urban Health. 2010 Mar;87(2):278–91. doi: 10.1007/s11524-009-9417-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Chandler RK, Fletcher BW, Volkow ND. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA. 2009 Jan;301(2):183–90. doi: 10.1001/jama.2008.976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Casriel C, Des Jarlais DC, Rodriguez R, Friedman SR, Stepherson B, Khuri E. Working with heroin sniffers: clinical issues in preventing drug injection. J Subst Abuse Treat. 1990;7(1):1–10. doi: 10.1016/0740-5472(90)90031-k. [DOI] [PubMed] [Google Scholar]
  • 77.Pantin H, Coatsworth JD, Feaster DJ, et al. Familias Unidas: the efficacy of an intervention to promote parental investment in Hispanic immigrant families. Prev Sci. 2003 Sep;4(3):189–201. doi: 10.1023/a:1024601906942. [DOI] [PubMed] [Google Scholar]
  • 78.Coatsworth JD, Pantin H, Szapocznik J. Familias Unidas: a family-centered ecodevelopmental intervention to reduce risk for problem behavior among Hispanic adolescents. Clin Child Fam Psychol Rev. 2002 Jun;5(2):113–32. doi: 10.1023/a:1015420503275. [DOI] [PubMed] [Google Scholar]
  • 79.Prendergast ML. Interventions to promote successful re-entry among drug-abusing parolees. Addict Sci Clin Pract. 2009 Apr;5(1):4–13. doi: 10.1151/ascp09514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998 Aug;51(3):253–68. doi: 10.1016/s0376-8716(98)00028-3. [DOI] [PubMed] [Google Scholar]

RESOURCES